Business in Romania blog: Doing business in Romania and business issues

The business in Romania blog writes about the Romanian business landscape, doing business in Romania, investing in Romania business and debating on business issues in Romania. Check this Blog's Policy here.

Sitemap | Feedback | Doing Business in Romania report | Opening a Business in Romania | RSS for this Blog

Thursday, November 04, 2004

Antibiotice net profit decreases

Drugmaker Antibiotice Iasi saw its net profits drop in the first nine months of the year by around 13% to 2.35 million euros. Turnover rose 2% to 23.4 million euros.

The main cause for the drop was the raising of the tax levied on drug exporters from the 6% of last year to 25%.

Antibiotice makes more than 7 million euros a year from exports to 35 countries and, according to Nani, accounts for more than 10% of the international Vitamin B12 market. The company expects a full-year turnover of 32.5 million euros, up 10% from 2003, and gross profits of over 4 million euros.

Antibiotice will soon begin an investment of approximately 2.5 million euros aimed mainly at upgrading and retooling its production platform (1.5 million euros) and environmental protection measures ( 0.75 million euros).

Posted by Mihai : 11/04/2004 02:34:00 pm